![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](hb2695contents.gif)
Acta Cryst. (2008). E64, o556 [ doi:10.1107/S1600536808003401 ]
Abstract: The title compound, C7H15N3P+·BF4- or [PTA-Me][BF4], is the N-methylated derivative of the well known water-soluble aminophosphine 1,3,5-triaza-7-phosphaadamantane (PTA). The asymmetric unit consists of a cage-like cation [PTA-Me]+ and a disordered tetrafluoroborate anion; two F atoms are disordered equally over two sites. A network of weak intermolecular C-H
F hydrogen bonds results in a three-dimensional supramolecular assembly.
Online 6 February 2008
Copyright © International Union of Crystallography
IUCr Webmaster